ReWalk Robotics Ltd. (NASDAQ: LFWD) is now covered by analysts at Laidlaw. They set a "buy" rating and a $10.00 price target on the stock.
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
Gait Trainer Market Set to Grow from USD 395.6 Million in 2025 to USD 637.8 Million by 2035 at a 4.9% of CAGR, Driven by Advanced Technologies | Future Market Insights, Inc. [Yahoo! Finance]
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities